MOESM1 of Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study

Additional file 1: Table S1. Cox regression for time to atrial fibrillation-overall, men and women. Table S2. Adjusted hazard ratios for atrial fibrillation and 95% confidence intervals for time-updated mean HbA1c categories, albuminuria categories and eGFR categories versus the reference group examined by Cox regression–Men. Table S3. Adjusted hazard ratios for atrial fibrillation and 95% confidence intervals for time-updated mean HbA1c categories, albuminuria categories and eGFR categories versus the reference group examined by Cox regression–Women. Table S4. Adjusted hazard ratios for atrial fribrillation and 95% confidence intervals for time-updated mean HbA1c categories together with albuminuria and eGFR versus the reference group examined by Cox regression–Men. Table S5. Adjusted hazard ratios for atrial fibrillation and 95% confidence intervals for time-updated mean HbA1c categories together with albuminuria and eGFR versus the reference group examined by Cox regression–Women. Table S6. The impact of time-updated mean HbA1c categories on time to first atrial fibrillation using Cox regression analysis among type 2 diabetes patients–Men. Table S7. The impact of time-updated mean HbA1c categories on time to first atrial fibrillation using Cox regression analysis among type 2 diabetes patients–Women.